glp-1 drugs pharmaceutical companies 2025 Healthcare and Pharma Shifts Driving Drug Delivery Growth in The Peptide Paradox: Why Miracle
Description
Powell-WileyTMPoirierPBurkeLEDesprsJPGordon-LarsenPLavieCJet alObesity and cardiovascular disease: a scientific statement from the American Heart Association
Prepare for more intensive utilization management as indications expand
doi: 10.1038/s41569-023-00849-3
GLP-1 drugs have been approved by the FDA for diabetes and weight loss, making way for GLP-1 patches for both indications
J Clin Endocrinol Metab 2011;96:13011310
Borner T, Geisler CE, Fortin SM, et al
